← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eldec Pharmaceuticals, Inc.
Durham, NC
$5,424,612
Total funding
6
Grants
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,424,612 · 6
By mechanism
R42$2,568,200 · 2
R44$2,072,426 · 1
R43$483,986 · 2
R41$300,000 · 1
Investigators at Eldec Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Novel Strategies to Clear Bacteria from the CF Lung$999,919
R44 · FY2022 · HL
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$999,840
R42 · FY2021 · AI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$988,238
R42 · FY2022 · AI
Novel Strategies to Clear Bacteria from the CF Lung$977,764
R44 · FY2023 · HL
Novel Peptide Fusion Inhibitors for the Treatment of COVID-19$300,000
R41 · FY2022 · AI
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung$300,000
R42 · FY2020 · AI
Novel peptide therapeutics to treat cystic fibrosis-related diabetes$280,122
R42 · FY2025 · DK
Novel Peptide Immunomodulators for Treating Sepsis$259,121
R43 · FY2023 · AI
Peptide therapies for treating CF lung inflammation$224,865
R43 · FY2018 · HL
Novel Strategies to Clear Bacteria from the CF Lung$94,743
R44 · FY2023 · HL